21.6 C
London
Friday, June 21, 2024

Emerging Growth Conference 73 - July 17 & 18, 2024 - Register now

More Headlines

Gilead Acquisition of CymaBay Rekindles Interest in Liver Disease

0
After a few years of disinterest in the MASH biotech subsector, 2024 has started off with a bang, reigniting investor interest in treating liver...

Graphene enhanced concrete continues to excel in field trials

0
Highlights Graphene enhanced concrete slab continues to perform well after >200 days in the field at a major UK highway infrastructure project Strength and...

Significant efficiency improvements achieved at Henderson graphene manufacturing facility

0
New German-made Retsch mill enables 60% improvement in downstream process efficiency and makes milling process 67% more cost effective A faster, more efficient...

New opportunities in green hydrogen production following positive electrocatalyst results

0
Graphene enhanced electrocatalysts give superior performance during the manufacture of ‘green hydrogen’ by water electrolysis PureGRAPH® combined with low-cost transition metals could produce...

Successful production of graphene oxide opens up new growth curve ,...

0
Highlights • Graphene oxide successfully produced at Henderson facility using a modified version of existing graphene production process • Sustainable and cost-effective process conducted with minimal...

Extending Commercialisation of PureGRAPH across a wide range of industries

0
Highlights Home building: UK eco-home building company continues to use graphene enhanced construction materials to improve fire retardancy and strength Automotive Lubricants: Graphene enhanced...

Epazz Holdings ZenaDrone Was Awarded Phase 1 US Air Force SBIR Dual-Purpose Technology Contract

0
Epazz, Inc. (OTC: EPAZ), a mission-critical provider of drone technology, blockchain mobile apps and cloud-based business software solutions, announced today one of its holdings,...

12 Best Bitcoin Mining Software for Windows PC

0
With the advent of blockchain technology, hundreds of different cryptocurrencies have appeared. Today, mining is available to almost everyone. Just make sure your computer...

AD-214 RETURNS TO CLINICAL STUDIES

0
Key points: First dosing of AD-214 achieved in Phase I extension study On track to obtain interim results in 2023, full results in...

Unlocking Chronic Diseases with Next-Gen i-body Platform Technology from AdAlta (1AD)

0
Unlocking Chronic Diseases with Next-Gen i-body Platform Technology from AdAlta (1AD) 1AD stock carries a dramatically undervalued profile against its blue-sky upside target Emerging Growth Report...